Turkey Regulatory Update: Erlotinib Conditions Spark Protests
This article was originally published in PharmAsia News
SGK’s proposal not to reimburse a lung cancer drug for patients who used to be smokers causes discord, while Turkish generic manufacturers are happy with government policies supporting local production. Turkish pharma exports increased by 10% last year while SGK has added several drugs to the reimbursement list.
Register for our free email digests: